期刊文献+

前列地尔治疗肝肾综合征35例 被引量:2

下载PDF
导出
摘要 目的观察前列地尔治疗肝肾综合征的疗效。方法将70例患者随机分为两组,治疗组35例,常规治疗加前列地尔注射液20μg静脉滴注,每天1次,疗程4周;对照组35例予常规治疗,疗程4周。治疗过程复查肝肾功能及腹腔积液B超,观察治疗前后肝肾功能及腹腔积液改善情况。结果治疗组的肝肾功能及腹腔积液较对照组明显改善(P<0.05),临床疗效优于对照组(P<0.05)。结论前列地尔注射液能有效治疗肝肾综合征,疗效肯定。
出处 《中国药业》 CAS 2012年第9期62-63,共2页 China Pharmaceuticals
  • 相关文献

参考文献2

二级参考文献21

  • 1Arroy V,Ginés P,Gerbes AL,et al.Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis[J].Hepatology,1996,33 (1):164-173.
  • 2Ginés P,Guevara M,Arroyo V,et al.Hepatorenal syndrome[J].Lancet,2003,362:1819-1827.
  • 3Dagher L,Moore K.The hepatorenal syndrome[J].Gut,2001,49:729-737.
  • 4田庚善,斯崇文.肝肾综合征.王叔咸,吴阶平.肾脏病学[M].北京:人民卫生出版社,1987.625-664.
  • 5Ginés P,Guevara M.Good news for hepatorenal syndrome[J].Hepatology,2002,36:504-506.
  • 6Ortega R,Ginés P,Uriz J,et al.Terlipressin therapy with and without albumin for patients with hepatorenal syndrome:results of a prospective,nonrandomized study[J].Hepatology,2002,36:941-948.
  • 7Guevara M,Ginés P,Fernandez-Esparrach G,et al.Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion[J].Hepatology,1998,27:35-41.
  • 8Gülberg V,Bilzer M,Gerbes AL.Long-term therapy and retreatment and of hepatorenal syndrome type Ⅰ with omipressin and dopamine[J].Hepatology,1999,30:870-875.
  • 9Duvoux C,Zanditenas D,Hezode C,et al.Effects of nonadrenalin and albumin in patients with type Ⅰ hepatorenal syndrome:a pilot study[J].Hepatology,2002,36:378-380.
  • 10Pomier-Layrargues G,Paquin SC,Hassoun Z,et al.Octreotide in hepatorenal syndrome:a randomized,double-blind,placebo-controlled,crossover study[J].Hepatology,2003,38:238-241.

共引文献132

同被引文献21

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部